Home Tags Opioid Crisis
Tag: Opioid Crisis
Pharma stocks plunged after federal prosecutors launched a criminal probe into their role in fueling the opioid crisis
Traders wiped more than $3 billion from the market caps of five drug companies after learning they received grand jury subpoenas.
Between 1999 and 2017, more than 218,000 people in the US died from overdoses related to prescription opioids.
Opioid distributors soar after reportedly offering $18 billion to settle a swath of drug crisis lawsuits
AmerisourceBergen, Cardinal Health, and McKesson surged more than 7% early Wednesday. The settlement would absolve state and local litigation.
‘Sesame Street’ is introducing a muppet whose mom has an opioid addiction, and people are having mixed feelings about it
Many are praising the show for giving kids the tools to deal with substance abuse, while others think it's "heartbreaking" and a "sad reality."
Johnson & Johnson climbs after settling two opioid epidemic lawsuits, allowing it to avoid an upcoming federal trial
The pharmaceutical giant paid $20.4 million to settle the two Ohio opioid lawsuits. J&J said the settlement includes no admission of liability.
130 Americans die each day from opioid overdoses. Experts are asking why a lifesaving treatment isn’t widely available without a prescription.
The antidote, naloxone, is supposed to be readily available at pharmacies in most states. But a report last year found that wasn't the case.
Purdue Pharma and its billionaire owners may end up giving billions in OxyContin profits to communities harmed by the opioid crisis
The proposal would mark a departure from the fates of other companies accused of stoking public-health crises.
Purdue Pharma is reportedly mulling an 8-figure settlement to resolve more than 2,000 opioid cases — and it would plunge the drugmaker into bank...
The settlement talks follow an Oklahoma judge's ruling against Johnson & Johnson in a similar case earlier this week.
J&J was ordered to pay $572 million for helping fuel the opioid epidemic. The company’s market cap increased $15 billion in response.
Johnson & Johnson's June regulatory filings revealed nearly $15 billion in cash reserves, signaling the company can easily pay the judge's fine.
Opioid distributors accused of fueling the national epidemic sink after offering a $10 billion settlement
The National Association of Attorneys General countered the providers' initial offer with a heftier $45 billion settlement.